JP2001233754A - Emulsion type skin care preparation - Google Patents

Emulsion type skin care preparation

Info

Publication number
JP2001233754A
JP2001233754A JP2000049078A JP2000049078A JP2001233754A JP 2001233754 A JP2001233754 A JP 2001233754A JP 2000049078 A JP2000049078 A JP 2000049078A JP 2000049078 A JP2000049078 A JP 2000049078A JP 2001233754 A JP2001233754 A JP 2001233754A
Authority
JP
Japan
Prior art keywords
ceramide
skin
mass
present
phospholipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000049078A
Other languages
Japanese (ja)
Inventor
Motoi Hayase
基 早瀬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Priority to JP2000049078A priority Critical patent/JP2001233754A/en
Publication of JP2001233754A publication Critical patent/JP2001233754A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a skin care preparation which has excellent storage stability and functional characteristics. SOLUTION: This emulsion type skin care preparation includes ceramide, phospholipid, a cholesterol complex, a liquid oil and hexyleneglycol.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、保存安定性、官能
特性に優れた乳化型皮膚外用剤に関する。
TECHNICAL FIELD The present invention relates to an emulsified external preparation for skin which has excellent storage stability and organoleptic properties.

【0002】[0002]

【従来の技術】脂質の一種であるセラミドは、生体内で
大部分を占めるグリセロ脂質に比べて量的には少ない
が、重要な生理的役割を持つ事が最近知られてきてい
る。セラミドはヒトを始めとする哺乳類での生体分布も
生理的に重要である場所に存在し、中でも脳、肝臓、皮
膚などに蓄積されている。
2. Description of the Related Art It has recently been known that ceramide, which is a kind of lipid, has an important physiological role although its quantity is smaller than that of glycerolipid which occupies most of the body. Ceramide exists in places where the biodistribution in mammals including humans is also physiologically important, and is accumulated especially in the brain, liver, skin and the like.

【0003】皮膚では特に表皮角質層にセラミドが蓄積
されている。これは表皮細胞によって合成分泌され、細
胞間に独特のラメラ構造を形成している細胞間脂質の主
成分となっている(Lukas Landmann:Anat Embryol ,第
178巻, 1−3頁, 1988年)。角質層は、皮膚の
保湿能や生体の物理的保護を始めとする一連の生理的役
割、いわゆるバリアー機能を持っているが、細胞間脂質
はこのバリアー機能の実体であり、生命維持において最
も重要な役割の一つを担っている(芋川玄爾:香粧会
誌、第15巻(4号)、250−253頁、1991
年)。この意味から、皮膚セラミドはバリア機能を担う
重要な物質の1つと言える。従って、皮膚上にセラミド
を含有する被膜を均一に形成させる事によって皮膚バリ
ア機能の改善が期待される。
[0003] In the skin, ceramide is accumulated particularly in the stratum corneum of the epidermis. It is synthesized and secreted by epidermal cells and is a major component of intercellular lipids forming a unique lamellar structure between cells (Lukas Landmann: Anat Embryol, 178, 1-3, 1988). . The stratum corneum has a series of physiological roles including the moisturizing ability of the skin and physical protection of the living body, so-called barrier functions, but intercellular lipids are the substance of this barrier function and are the most important in life support (Genji Imokawa: Journal of Koshokai, Vol. 15 (4), pp. 250-253, 1991)
Year). In this sense, it can be said that skin ceramide is one of the important substances responsible for the barrier function. Therefore, improvement of the skin barrier function is expected by uniformly forming a ceramide-containing coating on the skin.

【0004】しかしながらセラミドは、一般に皮膚外用
剤に用いる油剤や水に溶解しにくく、製剤化が非常に困
難であった。そこで、セラミドをリン脂質、ステロール
とともに有機溶剤に一度溶解し、溶剤を減圧下で除去す
る事により得られる複合体(以下、セラミド、リン脂質、
ステロール複合物という)を造る技術が生み出され、こ
れを用いた製剤の開発が行われてきたが、その場合でも
油分の配合が困難であり、機能を保持しうるだけのセラ
ミドと液状油を配合しながら官能特性、保存安定性に優
れた皮膚外用剤を得ることは困難であった。
[0004] However, ceramide is generally difficult to dissolve in oils and water used for external preparations for the skin, and it has been very difficult to formulate ceramide. Therefore, a complex (hereinafter, ceramide, phospholipid,
A technology for making sterol composites was created, and formulations were developed using these. However, even in such cases, blending of oil was difficult, and ceramide and liquid oil were blended to maintain their functions. However, it has been difficult to obtain a skin external preparation having excellent sensory characteristics and storage stability.

【0005】[0005]

【発明が解決しようとする課題】かかる事情に鑑み、本
発明者が種々検討した結果、セラミド、リン脂質、ステロ
ール複合物がヘキシレングリコール存在下で高い乳化力
を有する事を見出し、且つ、この乳化組生物が官能的に
優れ、且つ、保存安定性にも優れることを見出し、本発
明を完成するに至ったものであって、その目的とすると
ころは、官能特性、保存安定性に優れた皮膚外用剤を提
供するにある。
In view of such circumstances, as a result of various studies by the present inventors, they have found that ceramide, phospholipid, and sterol composites have a high emulsifying power in the presence of hexylene glycol. It has been found that the emulsified composition is functionally superior and has excellent storage stability, and has led to the completion of the present invention. An external skin preparation is provided.

【0006】[0006]

【課題を解決するための手段】上述の目的を達成する本
発明の請求項1は、セラミド、リン脂質、ステロール複合
物と液状油とヘキシレングリコールを含有する事を特徴
とする乳化型皮膚外用剤である。
The first object of the present invention to achieve the above object is to provide an emulsified type external skin containing ceramide, phospholipid, sterol compound, liquid oil and hexylene glycol. Agent.

【0007】[0007]

【発明の実施の形態】以下、本発明の実施の形態につい
て詳説する。
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Hereinafter, embodiments of the present invention will be described in detail.

【0008】本発明のセラミドは公知物質であり、一般
にタイプ1〜タイプ6と言われる各種構造のセラミドを
挙げる事が出来、例えば、N−ステアロイルフィトスフ
ィンゴシン(日光ケミカルズ社製)、セラミドHO3
(クローダジャパン社製)、セラミド2(高砂香料社製
TTC001)等がある。セラミドの本発明の複合体中
への配合量は5〜50質量%とするのが好ましく、特に
好ましくは10〜40質量%である。50質量%を超え
るとき、及び5質量%未満のとき、本発明の効果が充分
に発現されないことがある。
The ceramide of the present invention is a known substance and includes ceramides of various structures generally referred to as type 1 to type 6, such as N-stearoylphytosphingosine (manufactured by Nikko Chemicals Co., Ltd.) and ceramide HO3.
(Manufactured by Croda Japan) and Ceramide 2 (TTC001 manufactured by Takasago International Corporation). The amount of ceramide in the composite of the present invention is preferably 5 to 50% by mass, and particularly preferably 10 to 40% by mass. When the content is more than 50% by mass or less than 5% by mass, the effect of the present invention may not be sufficiently exhibited.

【0009】本発明に用いられるリン脂質は公知物質で
あり、スフィンゴミエリンや大豆、卵黄等由来の水素添
加レシチンを用いる事が出来、例えばコートソームNC
−21(日光ケミカルズ社製)、ホスホフォリポン90
H(日本精化社製)、YOK95(YMC社製)等を用
いる事が出来る。リン脂質の複合体中への配合量は30
〜80質量%とするのが好ましく、特に好ましくは35
〜70質量%である。80質量%を超えるとき、及び3
0質量%未満のとき、本発明の効果が充分に発現されな
いことがある。
[0009] The phospholipid used in the present invention is a known substance, and sphingomyelin, hydrogenated lecithin derived from soybean, egg yolk and the like can be used.
-21 (manufactured by Nikko Chemicals), Phosphophorpon 90
H (manufactured by Nippon Seika), YOK95 (manufactured by YMC) and the like can be used. The amount of the phospholipid in the complex is 30.
To 80% by mass, particularly preferably 35% by mass.
7070% by mass. More than 80% by mass, and 3
When the amount is less than 0% by mass, the effect of the present invention may not be sufficiently exhibited.

【0010】本発明に用いられるステロールは公知物質
であり、コレステロール、フィトステロール等が挙げら
れる。このステロールはステロールエステルを含まな
い。
[0010] The sterol used in the present invention is a known substance and includes cholesterol, phytosterol and the like. This sterol does not contain sterol esters.

【0011】本発明のセラミド、リン脂質、ステロール複
合物は、これらの脂質成分を有機溶媒に一度溶解し、溶媒
を減圧下で除去する事により調製されるもので、有機溶
媒としては、例えばペンタン、ヘキサン、ヘプタン、シ
クロヘキサンなどの炭化水素、塩化メチレン、クロロホ
ルム、ベンゼン、トルエン、メタノール、エタノール、
酢酸メチル、酢酸エチルなどを用いる事が出来る。有機
溶媒の使用量は特に限定されない。セラミド、リン脂質、
ステロール複合物として例えば(株)日本精化社製セラ
ミドプレソーム等を用いる事が出来るがこれに限定され
ない。セラミド、リン脂質、ステロール複合物の本発明の
乳化型皮膚外用剤への配合量は、組成物総量を基準とし
て、0.01〜10質量%とするのが好ましく、特に好
ましくは0.1〜3%質量である。10質量%を超える
とき、及び0.01質量%未満のとき、本発明の効果が
充分に発現されないことがある。
The ceramide, phospholipid, and sterol complex of the present invention is prepared by dissolving these lipid components in an organic solvent once and removing the solvent under reduced pressure. , Hydrocarbons such as hexane, heptane and cyclohexane, methylene chloride, chloroform, benzene, toluene, methanol, ethanol,
Methyl acetate, ethyl acetate and the like can be used. The amount of the organic solvent used is not particularly limited. Ceramide, phospholipids,
As the sterol composite, for example, ceramide presome manufactured by Nippon Seika Co., Ltd. or the like can be used, but it is not limited thereto. The amount of the ceramide, phospholipid, and sterol complex to be added to the emulsified skin external preparation of the present invention is preferably 0.01 to 10% by mass, and particularly preferably 0.1 to 3% by mass, based on the total amount of the composition. Mass. When the content is more than 10% by mass or less than 0.01% by mass, the effect of the present invention may not be sufficiently exhibited.

【0012】本発明に用いられる液状油は室温で液状の
ものであればよい。例えばジメチルポリシロキサン、メ
チルフェニルポリシロキサン、メチルセチルポリシロキ
サン、環状シリコーン等のシリコーン油、流動パラフィ
ン、オレフィンオリゴマー、スクワラン、ジオクチルヘ
キサノール等の炭化水素類、オリーブスクワラン、米ス
クワラン、米胚芽油、ホホバ油、杏仁油、ヒマシ油、紅
花油、オリーブ油、マカデミアナッツ油、ヒマワリ油、
菜種油、綿実油などの植物油、ミリスチン酸オクチルド
デシル、イソステアリン酸イソステアリル、ミリスチン
酸イソプロピル、乳酸イソステアリル等のエステル油、
イソステアリン酸、オレイン酸などの高級脂肪酸、トリ
カプリル・カプリン酸グリセリル、2−エチルヘキサン
酸グリセリル、イソステアリン酸トリグリセリルなどの
トリグリセリド、ジオクチルエーテル等のエーテル油等
を用いる事が出来る。これら液状油の本発明の乳化型皮
膚外用剤への配合量は、組成物総量を基準として、0.
05〜50質量%が好ましく、特に好ましくは0.1〜
40質量%である。
The liquid oil used in the present invention may be a liquid oil at room temperature. For example, silicone oils such as dimethylpolysiloxane, methylphenylpolysiloxane, methylcetylpolysiloxane, and cyclic silicone, liquid paraffin, olefin oligomers, hydrocarbons such as squalane, dioctylhexanol, olive squalane, rice squalane, rice germ oil, jojoba oil , Apricot kernel oil, castor oil, safflower oil, olive oil, macadamia nut oil, sunflower oil,
Rapeseed oil, vegetable oils such as cottonseed oil, ester oils such as octyldodecyl myristate, isostearyl isostearate, isopropyl myristate, and isostearyl lactate;
Higher fatty acids such as isostearic acid and oleic acid, triglycerides such as glyceryl tricapryl / caprate, glyceryl 2-ethylhexanoate, and triglyceryl isostearate, and ether oils such as dioctyl ether can be used. The amount of these liquid oils to be incorporated into the emulsified skin external preparation of the present invention is 0.1% based on the total amount of the composition.
It is preferably from 0.5 to 50% by mass, particularly preferably from 0.1 to 50% by mass.
40% by mass.

【0013】ヘキシレングリコールの本発明の乳化型皮
膚外用剤への配合量は、組成物総量を基準として、0.
1〜50質量%が好ましい。この配合量の上限を越える
と保存安定性が低下し、その越えた配合量に見合った効
果は期待できず、また、下限未満の配合量では本発明の
目的を達成することができないことがある。
The amount of hexylene glycol incorporated into the emulsified external preparation for skin of the present invention is 0.1% based on the total amount of the composition.
1-50 mass% is preferred. When the amount exceeds the upper limit of the amount, the storage stability is reduced, and an effect corresponding to the amount exceeding the amount cannot be expected.If the amount is less than the lower limit, the object of the present invention may not be achieved. .

【0014】本発明の乳化型皮膚外用剤の使用形態とし
ては、例えば軟膏、クリーム、ローション、乳液、パッ
ク、ジェルなどが挙げられ、医薬品、医薬部外品、化粧品
などに適用する事が出来る。
The form of use of the emulsified external skin preparation of the present invention includes, for example, ointments, creams, lotions, emulsions, packs, gels and the like, and can be applied to pharmaceuticals, quasi-drugs, cosmetics and the like.

【0015】本発明の乳化型皮膚外用剤には上記の他に
タール系色素、酸化鉄などの着色顔料、パラベン、フェ
ノキシエタノールなどの防腐剤、パラフィン、ワセリ
ン、オレフィノリゴマー、等の固形もしくは半固形の炭
化水素類、ミツロウ、モクロウ、カルナバロウ等のロウ
類、パルミチン酸セチル等の固形もしくは半固形のエス
テル油、エタノール等の低級アルコール類、セタノー
ル、ベヘニルアルコール、ステアリルアルコール、長鎖
分岐脂肪族アルコール等の高級アルコール類、分岐脂肪
酸コレステロールエステル、マカデミアナッツ脂肪酸フ
ィトステリルエステル等のステロール誘導体、硬化油等
の加工油類、ステアリン酸、パルミチン酸、ミリスチン
酸、イソ型長鎖脂肪酸、アンテイソ型長鎖脂肪酸などの
高級脂肪酸、リモネン、水素添加ビサボロール等のテル
ペン類、トリイソ型長鎖脂肪酸グリセリル、トリパルミ
チン酸グリセリルなどの固形もしくは半固形のトリグリ
セリド、セチル硫酸ナトリウム、N−ステアロイル−L
−グルタミン酸塩などの陰イオン界面活性剤、ポリオキ
シエチレンアルキルエーテル、ポリオキシエチレン脂肪
酸エステル、ポリオキシエチレン多価アルコール脂肪酸
エステル、ポリオキシエチレン硬化ヒマシ油、多価アル
コール脂肪酸エステル、ポリグリセリン脂肪酸エステ
ル、変性シリコーン、蔗糖エステルなどの非イオン界面
活性剤、テトラアルキルアンモニウム塩などの陽イオン
界面活性剤、ベタイン型、スルホベタイン型、スルホア
ミノ酸型などの両性界面活性剤、セレブロシドなどの天
然系界面活性剤、酸化チタン、酸化亜鉛などの顔料、ジ
ブチルヒドロキシトルエンなどの抗酸化剤、塩化ナトリ
ウム、塩化マグネシウム、硫酸ナトリウム、硝酸カリウ
ム等の無機塩類、クエン酸ナトリウム、酢酸カリウム、
琥珀酸ナトリウム、アスパラギン酸ナトリウム、乳酸ナ
トリウム等の有機酸塩類、塩酸エタノールアミン、硝酸
アンモニウム、塩酸アルギニン等の塩類、エデト酸等の
キレート剤、キサンタンガム、カルボキシビニルポリマ
ー、カラギーナン、ペクチン、アルキル変性カルボキシ
ビニルポリマー、アルカリゲネスレータスB16ポリマ
ー、寒天等の増粘剤、水酸化カリウム、ジイソプロパノ
ールアミン、トリエタノールアミン等の中和剤、ヒアル
ロン酸、コラーゲン等の生体高分子、乳酸菌、酵母、ク
リタケなどの培養生成物、カミツレ、マツ、オウバク、
オウレン、アロエ、モモ、カロット、スギナ、オレン
ジ、クワ、桃の葉、セージ、ビワ葉、キュウカンバー、
セイヨウキズタ、ハイビスカス、ウコン、ローズマリ
ー、ピーカンナッツ、海藻、甘草、火棘、椿種子、茶の
実等の植物エキス、胎盤抽出物、ヒドロキシメトキシベ
ンゾフェノンスルフォン酸塩等の紫外線吸収剤、ジプロ
ピレングリコール、1,3ブチレングリコール、グリセ
リン、プロピレングリコール、ソルビトール、マルビト
ール、ジグリセリン、ラフィノースなどの多価アルコー
ル等が挙げられるがこれに限定されるものではない。
[0015] In addition to the above, the emulsified skin external preparation of the present invention may further comprise a solid or semi-solid such as tar pigments, coloring pigments such as iron oxide, preservatives such as paraben and phenoxyethanol, paraffin, petrolatum, olefinoligomer, and the like. Hydrocarbons, beeswax, beeswax, wax such as carnauba wax, solid or semi-solid ester oils such as cetyl palmitate, lower alcohols such as ethanol, cetanol, behenyl alcohol, stearyl alcohol, and long-chain branched aliphatic alcohols Higher alcohols, branched fatty acid cholesterol esters, sterol derivatives such as macadamia nut fatty acid phytosteryl esters, processing oils such as hardened oils, higher grades such as stearic acid, palmitic acid, myristic acid, iso long chain fatty acids, and anteiso long chain fatty acids Fatty acids, limonene Terpenes such as hydrogenated bisabolol, triiso-type long chain fatty acid glyceryl, solid or semi-solid triglycerides such as tripalmitin glyceryl, sodium cetyl sulfate, N- stearoyl -L
-Anionic surfactants such as glutamate, polyoxyethylene alkyl ether, polyoxyethylene fatty acid ester, polyoxyethylene polyhydric alcohol fatty acid ester, polyoxyethylene hydrogenated castor oil, polyhydric alcohol fatty acid ester, polyglycerin fatty acid ester, Nonionic surfactants such as modified silicones and sucrose esters, cationic surfactants such as tetraalkylammonium salts, amphoteric surfactants such as betaine type, sulfobetaine type and sulfoamino acid type, and natural surfactants such as cerebroside , Pigments such as titanium oxide and zinc oxide, antioxidants such as dibutylhydroxytoluene, inorganic salts such as sodium chloride, magnesium chloride, sodium sulfate and potassium nitrate, sodium citrate, potassium acetate,
Organic acid salts such as sodium succinate, sodium aspartate and sodium lactate, salts such as ethanolamine hydrochloride, ammonium nitrate and arginine hydrochloride, chelating agents such as edetic acid, xanthan gum, carboxyvinyl polymer, carrageenan, pectin, alkyl-modified carboxyvinyl polymer , Alkaline gnestreas B16 polymer, thickeners such as agar, neutralizing agents such as potassium hydroxide, diisopropanolamine and triethanolamine, biopolymers such as hyaluronic acid and collagen, lactic acid bacteria, yeast, and mushrooms Objects, chamomile, pine, oak,
Spinach, aloe, peach, carrot, horsetail, orange, mulberry, peach leaf, sage, loquat leaf, cucumber,
Plant extracts such as vegetation, hibiscus, turmeric, rosemary, pecan nuts, seaweed, licorice, fire spikes, camellia seeds, tea seeds, placental extracts, ultraviolet absorbers such as hydroxymethoxybenzophenone sulfonate, dipropylene glycol , 1,3-butylene glycol, glycerin, propylene glycol, sorbitol, malbitol, diglycerin, polyhydric alcohols such as raffinose, and the like, but are not limited thereto.

【0016】[0016]

【実施例】以下、実施例、比較例、応用例により詳細に
説明する。尚、実施例、比較例、処方例中の配合量の単
位は質量%で、評価方法は次の通りである。
The present invention will be described below in more detail with reference to examples, comparative examples, and applied examples. The unit of the blending amount in Examples, Comparative Examples and Formulation Examples is% by mass, and the evaluation method is as follows.

【0017】官能試験 成人女性20名が顔面に実施例及び比較例の試料を塗布
し、べたつき、ぬるつきを感じなかった人数で評価し
た。 保存安定性試験 実施例及び比較例の各試料100mlをガラスビンに入
れ、室温で2日間放置し、析出・クリーミング・油膜な
どが観察されないものを○、観察されたものを×とし
た。
Sensory test Twenty adult women applied the samples of Examples and Comparative Examples to the face and evaluated the number of persons who did not feel sticky or slimy. Storage stability test 100 ml of each sample of Examples and Comparative Examples was placed in a glass bottle and allowed to stand at room temperature for 2 days. A sample in which no precipitation, creaming, oil film, etc. was observed was evaluated as ○, and an observed one was evaluated as ×.

【0018】実施例1〜11,比較例1〜3(スキンク
リーム) 表1に記載の実施例1〜11の乳化型皮膚外用剤、およ
び比較例1〜2の組成物を常法により調製後、これを試
料として官能試験、保存安定試験を行った。なお、ここ
ではセラミド、リン脂質、ステロール複合物として日本精
化社製セラミドプレソーム(N−ステアロイルフィトス
フィンゴシン:リン脂質:コレステロール=4:4:
2,質量比)又はセラミドプレソームK(光学活性体セ
ラミド2:リン脂質:コレステロール=4:4:2,質
量比)を用い、以下これらをそれぞれプレソーム、プレ
ソームKと略記する。試験結果を表1、2に示す。
Examples 1 to 11 and Comparative Examples 1 to 3 (skin cream) After preparation of the emulsified skin external preparations of Examples 1 to 11 shown in Table 1 and the compositions of Comparative Examples 1 and 2 by a conventional method. Using this as a sample, a sensory test and a storage stability test were performed. Here, ceramide presome (N-stearoyl phytosphingosine: phospholipid: cholesterol = 4: 4: manufactured by Nippon Seika Co., Ltd.) as a ceramide, phospholipid, and sterol complex.
2, mass ratio) or ceramide presome K (optically active ceramide 2: phospholipid: cholesterol = 4: 4: 2, mass ratio), which are hereinafter abbreviated as presome and presome K, respectively. The test results are shown in Tables 1 and 2.

【0019】[0019]

【表1】 [Table 1]

【0020】[0020]

【表2】 [Table 2]

【0021】本発明の乳化型皮膚外用剤は比較例の組成
物と比べて、すぐれた官能特性、保存安定性が認められ
た。
The emulsified external preparation for skin of the present invention was found to have excellent organoleptic properties and storage stability as compared with the composition of Comparative Example.

【0022】以下、本発明の乳化型皮膚外用剤の処方例
を示す。
The formulation examples of the emulsified external skin preparation of the present invention are shown below.

【0023】処方例1〜3 セラミド、リン脂質、コレステロール複合物、液状油、ヘ
キシレングリコールを表3の組成で次の調製方法によっ
てそれぞれを配合し、スキンクリームを調製した。
Formulation Examples 1 to 3 Ceramide, phospholipid, cholesterol complex, liquid oil, and hexylene glycol were blended in the compositions shown in Table 3 according to the following preparation methods to prepare skin creams.

【0024】[0024]

【表3】 [Table 3]

【0025】(A)成分および(B)成分を各々80℃
に加熱溶解した後、混合して攪拌しつつ冷却し、30℃
まで冷却後、スキンクリームを調製した。
The components (A) and (B) were each heated to 80 ° C.
After heating and dissolving in water, mix and cool while stirring
After cooling down, a skin cream was prepared.

【0026】応用例4〜6 セラミド、リン脂質、コレステロール複合物、液状油、ヘ
キシレングリコールを表4の組成で次の調製方法によっ
てそれぞれを配合し、乳液を調製した。
Application Examples 4 to 6 Ceramide, phospholipid, cholesterol complex, liquid oil, and hexylene glycol were blended according to the following preparation method with the compositions shown in Table 4 to prepare emulsions.

【0027】[0027]

【表4】 [Table 4]

【0028】成分をそれぞれ80℃にて混合溶解し、3
0℃まで冷却後、乳液を調製した。
The components were mixed and dissolved at 80 ° C.
After cooling to 0 ° C., an emulsion was prepared.

【0029】応用例7〜9(美容液) セラミド、リン脂質、コレステロール複合物、液状油、ヘ
キシレングリコールを表5の組成で次の調製方法によっ
てそれぞれを配合し、美容液を調製した。
Application Examples 7 to 9 (Essence) Serum, a phospholipid, a cholesterol complex, a liquid oil, and hexylene glycol were blended with the compositions shown in Table 5 according to the following preparation methods to prepare a serum.

【0030】[0030]

【表5】 [Table 5]

【0031】(A)成分および(B)成分を各々80℃
に加熱溶解した後、混合して攪拌しつつ冷却し、30℃
まで冷却後、美容液を調製した。
The components (A) and (B) were each heated to 80 ° C.
After heating and dissolving in water, mix and cool while stirring
After cooling, a serum was prepared.

【0032】処方例10〜12 セラミド、リン脂質、コレステロール複合物、液状油、ヘ
キシレングリコールを表6の組成で次の調製方法によっ
てそれぞれを配合し、サンスクリーン剤を調製した。
Formulation Examples 10 to 12 A ceramide, a phospholipid, a cholesterol complex, a liquid oil, and hexylene glycol were blended in the compositions shown in Table 6 according to the following preparation method to prepare a sunscreen.

【0033】[0033]

【表6】 [Table 6]

【0034】(A)成分および(B)成分を各々80℃
に加熱溶解した後、混合して攪拌しつつ冷却し、30℃
まで冷却後、サンスクリーンを調製した。
The components (A) and (B) were each heated to 80 ° C.
After heating and dissolving in water, mix and cool while stirring
After cooling, a sunscreen was prepared.

【0035】[0035]

【発明の効果】以上の如く、本発明が、保存安定性、官
能特性に優れた乳化型皮膚外用剤を提供することは明ら
かである。
As described above, it is apparent that the present invention provides an emulsified skin external preparation having excellent storage stability and organoleptic properties.

───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 4C083 AA012 AA032 AA082 AA112 AA122 AB032 AB212 AB242 AB342 AC012 AC022 AC072 AC111 AC112 AC122 AC132 AC172 AC262 AC302 AC342 AC352 AC422 AC432 AC442 AC482 AC532 AC582 AC622 AC641 AC642 AC662 AC852 AD042 AD092 AD152 AD172 AD202 AD212 AD312 AD332 AD352 AD491 AD492 AD532 AD571 AD622 AD642 AD662 BB13 CC02 CC05 DD31 EE01 ──────────────────────────────────────────────────続 き Continued on the front page F-term (reference) 4C083 AA012 AA032 AA082 AA112 AA122 AB032 AB212 AB242 AB342 AC012 AC022 AC072 AC111 AC112 AC122 AC132 AC172 AC262 AC302 AC342 AC352 AC422 AC432 AC442 AC482 AC532 AC582 AC622 AC641 AC642 AC662 AD152AD04AD2 AD212 AD312 AD332 AD352 AD491 AD492 AD532 AD571 AD622 AD642 AD662 BB13 CC02 CC05 DD31 EE01

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 セラミド、リン脂質、ステロール複合物と
液状油とヘキシレングリコールを含有する事を特徴とす
る乳化型皮膚外用剤。
1. An emulsified external skin preparation comprising ceramide, phospholipid, sterol complex, liquid oil and hexylene glycol.
JP2000049078A 2000-02-25 2000-02-25 Emulsion type skin care preparation Pending JP2001233754A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000049078A JP2001233754A (en) 2000-02-25 2000-02-25 Emulsion type skin care preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000049078A JP2001233754A (en) 2000-02-25 2000-02-25 Emulsion type skin care preparation

Publications (1)

Publication Number Publication Date
JP2001233754A true JP2001233754A (en) 2001-08-28

Family

ID=18571064

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000049078A Pending JP2001233754A (en) 2000-02-25 2000-02-25 Emulsion type skin care preparation

Country Status (1)

Country Link
JP (1) JP2001233754A (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002322045A (en) * 2000-12-21 2002-11-08 Johnson & Johnson Consumer Co Inc Care composition for personal use
WO2003049709A1 (en) * 2001-12-10 2003-06-19 Kao Corporation Ceramide emulsions
WO2003072070A1 (en) * 2002-02-27 2003-09-04 Hakuto Co., Ltd. Method of stabilizing silicone oil-containing cosmetic composition
JP2004107227A (en) * 2002-09-13 2004-04-08 Kao Corp Skin cosmetic
JP2004175670A (en) * 2002-11-22 2004-06-24 Kao Corp Oil-in-water type emulsified cosmetic
JPWO2003082224A1 (en) * 2002-03-29 2005-07-28 株式会社コーセー Cosmetics
JP2005220031A (en) * 2004-02-03 2005-08-18 Pola Chem Ind Inc Cosmetic containing aromatic-group-having aliphatic alcohol
JP2008019230A (en) * 2006-06-16 2008-01-31 Pola Chem Ind Inc Ceramide-containing external preparation for skin
JP2008120731A (en) * 2006-11-13 2008-05-29 Kose Corp Vesicle composition and external preparation for skin, compounded with the composition
JP2008290951A (en) * 2007-05-22 2008-12-04 Mikimoto Pharmaceut Co Ltd Emulsion composition
JP2020183343A (en) * 2019-04-26 2020-11-12 株式会社ナノエッグ External composition
JP7498577B2 (en) 2020-03-02 2024-06-12 花王株式会社 Oil-in-water emulsion cosmetics

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002322045A (en) * 2000-12-21 2002-11-08 Johnson & Johnson Consumer Co Inc Care composition for personal use
US7846969B2 (en) 2001-12-10 2010-12-07 Kao Corporation Ceramide emulsions
WO2003049709A1 (en) * 2001-12-10 2003-06-19 Kao Corporation Ceramide emulsions
WO2003072070A1 (en) * 2002-02-27 2003-09-04 Hakuto Co., Ltd. Method of stabilizing silicone oil-containing cosmetic composition
JPWO2003082224A1 (en) * 2002-03-29 2005-07-28 株式会社コーセー Cosmetics
CN100352414C (en) * 2002-03-29 2007-12-05 株式会社高丝 Cosmetic preparation
JP2004107227A (en) * 2002-09-13 2004-04-08 Kao Corp Skin cosmetic
JP2004175670A (en) * 2002-11-22 2004-06-24 Kao Corp Oil-in-water type emulsified cosmetic
JP2005220031A (en) * 2004-02-03 2005-08-18 Pola Chem Ind Inc Cosmetic containing aromatic-group-having aliphatic alcohol
JP2008019230A (en) * 2006-06-16 2008-01-31 Pola Chem Ind Inc Ceramide-containing external preparation for skin
JP2008120731A (en) * 2006-11-13 2008-05-29 Kose Corp Vesicle composition and external preparation for skin, compounded with the composition
JP2008290951A (en) * 2007-05-22 2008-12-04 Mikimoto Pharmaceut Co Ltd Emulsion composition
JP2020183343A (en) * 2019-04-26 2020-11-12 株式会社ナノエッグ External composition
JP7006947B2 (en) 2019-04-26 2022-01-24 株式会社ナノエッグ External composition
JP7498577B2 (en) 2020-03-02 2024-06-12 花王株式会社 Oil-in-water emulsion cosmetics

Similar Documents

Publication Publication Date Title
JP4527530B2 (en) Vesicle dispersion and cosmetics containing the same
KR101867847B1 (en) O/W Emulsion having recrystallized particle and Cosmetic composition comprising thereof
JP2001233754A (en) Emulsion type skin care preparation
JP2002068957A (en) Emulsion-type skin care preparation
KR101003847B1 (en) Skin -like complex composition
JP2017171649A (en) Having liposome compositions with high percutaneous absorption properties, and cosmetics or skin external preparations containing the same
JP2002161027A (en) Method for suppressing inflammation and erythema and composition therefor
JP6356457B2 (en) Ceramide-containing external preparation composition
JP5306725B2 (en) Topical skin preparation
WO2015064681A1 (en) Composition for external use
JP4067211B2 (en) Skin preparation
TW200916118A (en) External preparation for skin
WO2009044248A2 (en) Cosmetic and dermopharmaceutical compositions for skin barrier restoration and disorders prevention
JPH0196109A (en) Skin-beautifying cosmetic
JP3441387B2 (en) Moisturizer, skin cosmetics and bath additives
JP3568983B2 (en) Hair restorer
JP5641665B2 (en) External preparation for skin and method for producing the same
JP2016088872A (en) TEXTURE IMPROVING AGENT IN WHICH α GEL-STRUCTURE IS FORMED, AND COSMETIC OR EXTERNAL SKIN PREPARATION FOR IMPROVING TEXTURE CONTAINING THE SAME
JPH09124500A (en) Therapeutic agent for atopic dermatitis
JP3712673B2 (en) Gel composition and oil-in-water (O / W) type composition
JP4703809B2 (en) Topical skin preparation
JPH11269033A (en) Skin treatment agent
JP2002179549A (en) Skin care preparation
JP2001335411A (en) Hydrophilic emulsified skin care preparation
JP2003238383A (en) Skin care preparation

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20040805

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20040806

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20060328

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060425

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20070829

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070904

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20071127

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080212

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20100308